Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience-Reference-Cited by-同舟云学术

Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience

Published:2007-05 Issue:3 Volume:13 Page:244-248
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

SCHNEIDERMAN J.,RUBIN E.,NUGENT D. J.,YOUNG G.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01451.x/fullpdf

Reference8 articles.

1. The Hemophilias — From Royal Genes to Gene Therapy

2. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99

3. New Approaches in the Management of Inhibitor Patients

4. Possible Synergy between Recombinant Factor VIIa and Prothrombin Complex Concentrate in Hemophilia Therapy

5. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro;Thrombosis Research;2024-05

2. Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies;Medicina;2023-09-28

3. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders;Annals of Hematology;2023-06-30

4. RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia;Journal of Cellular and Molecular Medicine;2023-06-14

5. Factor VIIa/factor X製剤と高用量recombinant factor VIIa製剤の併用療法を施行した血友病Bインヒビター1症例の凝固能評価;Japanese Journal of Thrombosis and Hemostasis;2023